Campbell & Co. Investment Adviser »

Theravance Biopharma shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-03-31 $139k 16k 8.97
2022-03-31 $240k 25k 9.56
2021-09-30 $201k 27k 7.39
2019-12-31 $231k 8.9k 25.87

More positions owned by Campbell & Co. Investment Adviser

United Rentals Common Stock (URI)
Parker-Hannifin Corp Common Stock (PH)
TE Connectivity Common Stock (TEL)
Nov Common Stock (NOV)
Revvity Common Stock (RVTY)
DuPont de Nemours Common Stock (DD)
Credit Acceptance Corp Common Stock (CACC)
State Street Corp Common Stock (STT)
Franklin Resources Common Stock (BEN)
Chubb Common Stock (CB)
McKesson Corp Common Stock (MCK)
Cheniere Energy Common Stock (LNG)
Idacorp Common Stock (IDA)
Jack Henry & Associates Common Stock (JKHY)
Nordson Corp Common Stock (NDSN)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Theravance Biopharma

Weiss Asset Management LP[1
Madison Avenue Partners
BlackRock
Irenic Capital Management
Vanguard Group
Pictet Asset Management Holding SA
Newtyn Management
Oasis Management
Park West Asset Management
Geode Capital Management
D. E. Shaw & Co
Jacobs Levy Equity Management
Bank of America Corporation
Northern Trust
Morgan Stanley

View all funds holding Theravance Biopharma